A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.